Home›Procurement News - United States FDA Approves Mercks RECARBRIO imipenem cilastatin and relebactam For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available, United states (445871238)
Procurement News
Procurement News
News TI Ref No
445871238
News Date
22 Jul 2019
News Description
United States FDA Approves Mercks RECARBRIO imipenem cilastatin and relebactam For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available
Tender Deadline
⏰ 22 Jul 2019Closing soon
News Project Location
United States
News Sector
Banking, Finance, Insurance and Securities (BFIS) TendersHealthcare and Medical TendersServices Tenders
